Published in Drug Saf on January 01, 2004
Selective Modulators of PPAR-gamma Activity: Molecular Aspects Related to Obesity and Side-Effects. PPAR Res (2007) 1.18
Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome. Cardiovasc Diabetol (2005) 0.98
Genetic polymorphism of ACE and the angiotensin II type1 receptor genes in children with chronic kidney disease. J Inflamm (Lond) (2011) 0.86
New standards in hypertension and cardiovascular risk management: focus on telmisartan. Vasc Health Risk Manag (2010) 0.82
High prevalence of ACE DD genotype among north Indian end stage renal disease patients. BMC Nephrol (2006) 0.80
Metabolic effects of telmisartan in spontaneously hypertensive rats. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.77
Factors associated with efficacy of an ibuprofen/pseudoephedrine combination drug in pharmacy customers with common cold symptoms. Int J Clin Pract (2016) 0.75
Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension? Vasc Health Risk Manag (2007) 0.75
Effects of telmisartan on office and 24-hour ambulatory blood pressure: an observational study in hypertensive patients managed in primary care. Vasc Health Risk Manag (2010) 0.75
Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA (2009) 3.83
Progression of aortic pulse wave velocity in patients with chronic kidney disease. J Clin Hypertens (Greenwich) (2013) 2.06
Association of ambulatory arterial stiffness index and brachial pulse pressure is restricted to dippers. J Hypertens (2008) 1.77
Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Mov Disord (2003) 1.69
Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study. Radiology (2006) 1.68
Aortic pulse wave velocity predicts mortality in chronic kidney disease stages 2-4. J Hypertens (2014) 1.68
The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation. J Mol Med (Berl) (2008) 1.58
Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET. Nephrol Dial Transplant (2009) 1.58
Relapsing polychondritis: An autoimmune disease with many faces. Autoimmun Rev (2010) 1.47
Direct renin inhibition in a rat model of chronic allograft injury. Transplantation (2011) 1.42
Sexual dimorphism in renal ischemia-reperfusion injury in rats: possible role of endothelin. Kidney Int (2002) 1.41
Aortic to brachial pulse pressure amplification as functional marker and predictor of renal function loss in chronic kidney disease. J Clin Hypertens (Greenwich) (2014) 1.41
Behavioral conditioning of immunosuppression is possible in humans. FASEB J (2002) 1.29
Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation. Nephrol Dial Transplant (2009) 1.27
Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells. Nephrol Dial Transplant (2004) 1.22
Association of hypertension with symptoms of benign prostatic hyperplasia. J Urol (2004) 1.21
Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study. Transplantation (2005) 1.17
Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function. Clin Endocrinol (Oxf) (2007) 1.16
Expression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer. PLoS One (2013) 1.13
Spore dipicolinic acid contents used for estimating the number of endospores in sediments. FEMS Microbiol Ecol (2007) 1.12
Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial. Mov Disord (2005) 1.09
Hypertension augments cardiac Toll-like receptor 4 expression and activity. Hypertens Res (2011) 1.08
Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial. Circulation (2004) 1.06
Specific bacterial, archaeal, and eukaryotic communities in tidal-flat sediments along a vertical profile of several meters. Appl Environ Microbiol (2006) 1.05
Anti-glomerular basement membrane antibody disease: a rare autoimmune disorder affecting the kidney and the lung. Autoimmun Rev (2012) 1.04
Multi-modal treatment of calciphylaxis with sodium-thiosulfate, cinacalcet and sevelamer including long-term data. Kidney Blood Press Res (2013) 1.04
Association between carotid diameter and the advanced glycation end product N-epsilon-carboxymethyllysine (CML). Cardiovasc Diabetol (2009) 1.02
Tumours after kidney transplantation. Curr Opin Urol (2003) 1.02
The effect of ischemia/reperfusion on the kidney graft. Curr Opin Organ Transplant (2014) 1.00
Microbial diversity of a heavily polluted microbial mat and its community changes following degradation of petroleum compounds. Appl Environ Microbiol (2002) 0.99
Administration of interleukin-1 receptor antagonist ameliorates renal ischemia-reperfusion injury. Transpl Int (2008) 0.99
Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.97
Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation. Transpl Int (2009) 0.97
Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation. J Inflamm (Lond) (2010) 0.97
Early application of Met-RANTES ameliorates chronic allograft nephropathy. Kidney Int (2002) 0.97
STAT1-mediated signal integration between IFNγ and LPS leads to increased EC and SMC activation and monocyte adhesion. Am J Physiol Cell Physiol (2011) 0.95
Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression. Eur J Cancer (2010) 0.93
Donor antigen-specific regulatory T-cell function affects outcome in kidney transplant recipients. Kidney Int (2011) 0.92
Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury. Pediatr Nephrol (2010) 0.92
Effect of short-term high-protein compared with normal-protein diets on renal hemodynamics and associated variables in healthy young men. Am J Clin Nutr (2009) 0.92
Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes. Diabetes (2009) 0.91
Aspects of quality of life through end-stage renal disease. Qual Life Res (2003) 0.90
Damage-associated molecular pattern activated Toll-like receptor 4 signalling modulates blood pressure in L-NAME-induced hypertension. Cardiovasc Res (2013) 0.90
Differential diagnosis of unpleasant sensations in the legs: prevalence of restless legs syndrome in a primary care population. Sleep Med (2009) 0.89
[Quality of life in patients before and after kidney transplantation]. Psychother Psychosom Med Psychol (2002) 0.89
Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy. Cardiovasc Diabetol (2010) 0.88
Inhibition of matrix metalloproteinases during chronic allograft nephropathy in rats. Transplantation (2005) 0.88
The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial. J Hypertens (2005) 0.88
Renoprotective effect of erythropoietin in rats subjected to ischemia/reperfusion injury: gender differences. Surgery (2011) 0.88
Fumaric acid esters are potent immunosuppressants: inhibition of acute and chronic rejection in rat kidney transplantation models by methyl hydrogen fumarate. Arch Dermatol Res (2002) 0.86
C-terminal agrin fragment--a new fast biomarker for kidney function in renal transplant recipients. Am J Nephrol (2013) 0.85
Effect of Renin-Angiotensin system blockade on insulin resistance and inflammatory parameters in patients with impaired glucose tolerance. Diabetes Care (2010) 0.85
MEIS1 and BTBD9: genetic association with restless leg syndrome in end stage renal disease. J Med Genet (2011) 0.85
Distribution of candidate division JS1 and other Bacteria in tidal sediments of the German Wadden Sea using targeted 16S rRNA gene PCR-DGGE. FEMS Microbiol Ecol (2007) 0.84
Serum fetuin-A, cardiovascular risk factors, and six-year follow-up outcome in patients with coronary heart disease. Am J Cardiol (2010) 0.84
Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer. Eur J Cancer (2010) 0.84
N epsilon-(carboxymethyl)lysine during the early development of hypertension. Ann N Y Acad Sci (2007) 0.84
STAT1 as a central mediator of IFNγ and TLR4 signal integration in vascular dysfunction. JAKSTAT (2012) 0.84
Kidney function and clinical recommendations of drug dose adjustment in geriatric patients. BMC Geriatr (2013) 0.83
A highly sensitive HPLC method for determination of nanomolar concentrations of dipicolinic acid, a characteristic constituent of bacterial endospores. J Microbiol Methods (2007) 0.83
Degradation of petroleum model compounds immobilized on clay by a hypersaline microbial mat. Biodegradation (2002) 0.83
Comparison of immunoassays for the selective measurement of human high-molecular weight adiponectin. Clin Chem (2009) 0.83
Pramipexole in routine clinical practice: a prospective observational trial in Parkinson's disease. CNS Drugs (2003) 0.83
Microvascular dysfunction in the course of metabolic syndrome induced by high-fat diet. Cardiovasc Diabetol (2014) 0.83
C-terminal agrin fragment (CAF) as a serum biomarker for residual renal function in peritoneal dialysis patients. Int Urol Nephrol (2014) 0.83
Opposite effects of testosterone and estrogens on chronic allograft nephropathy. Transpl Int (2002) 0.83
Quality of life in kidney recipients: comparison of tacrolimus and cyclosporine-microemulsion. Clin Transplant (2002) 0.83
Myeloid-related protein 8/14 complex describes microcirculatory alterations in patients with type 2 diabetes and nephropathy. Cardiovasc Diabetol (2009) 0.83
Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) guidelines on kidney transplantation: a European Renal Best Practice (ERBP) position statement. Nephrol Dial Transplant (2011) 0.82
ICOS/B7RP-1 interference in mouse kidney transplantation. Transplantation (2007) 0.82
The serum and glucocorticoid-regulated kinase 1 in hypoxic renal injury. Cell Physiol Biochem (2009) 0.82
Renal N(epsilon)-carboxymethyllysine deposition after kidney transplantation. Transplantation (2008) 0.82
Association between heat shock protein 70s and toll-like receptor polymorphisms with long-term renal allograft survival. Transpl Int (2006) 0.82
Apoptosis and treatment of chronic allograft nephropathy with everolimus. Transplantation (2003) 0.81
Prehypertensive preconditioning improves adult antihypertensive and cardioprotective treatment. J Pharmacol Exp Ther (2009) 0.81
State of living kidney donation in Europe. Nephrol Dial Transplant (2012) 0.81
New model for simultaneous heart and kidney transplantation in mice. Microsurgery (2003) 0.81
Non-diabetic chronic kidney disease influences retinal microvasculature. Kidney Blood Press Res (2009) 0.81
A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib. J Am Coll Cardiol (2005) 0.81
Effects of progesterone and selective oestrogen receptor modulators on chronic allograft nephropathy in rats. Nephrol Dial Transplant (2004) 0.81
Role of serum and glucocorticoid-regulated kinase-1 in the protective effects of erythropoietin during renal ischemia/reperfusion injury. Biochem Pharmacol (2009) 0.80
ATP protects, by way of receptor-mediated mechanisms, against hypoxia-induced injury in renal proximal tubules. J Lab Clin Med (2003) 0.80
Ezetimibe treatment in hypercholesterolemic kidney transplant patients is safe and effective and reduces the decline of renal allograft function: a pilot study. Nephrol Dial Transplant (2007) 0.80
Gammaproteobacteria as a possible source of eicosapentaenoic acid in anoxic intertidal sediments. Microb Ecol (2008) 0.80
Expression of a disintegrin and metalloprotease in human abdominal aortic aneurysms. J Vasc Res (2012) 0.79
Bismuth coating of non-tunneled haemodialysis catheters reduces bacterial colonization: a randomized controlled trial. Nephrol Dial Transplant (2010) 0.79
Lithium poisoning: pharmacokinetics and clearance during different therapeutic measures. J Clin Psychopharmacol (2006) 0.79
Early postoperative C-terminal agrin fragment (CAF) serum levels predict graft loss and proteinuria in renal transplant recipients. Clin Chem Lab Med (2016) 0.79
Doppler-ultrasound measurements in renal allografts depend on the patient's body position. Vasa (2012) 0.79
Pulsatile stress correlates with (micro-)albuminuria in renal transplant recipients. Transpl Int (2009) 0.79
Effect of inhibition of neuronal nitric oxide synthase and L-arginine supplementation on renal ischaemia-reperfusion injury and the renal nitric oxide system. Clin Exp Pharmacol Physiol (2008) 0.79
Treatment of relapsing polychondritis with the TNF-alpha antagonist adalimumab. Clin Rheumatol (2010) 0.78
Retinal pulse wave velocity in young male normotensive and mildly hypertensive subjects. Microcirculation (2013) 0.78
MRP8/14 is associated with systemic inflammation in stable coronary atherosclerosis in men. Eur J Clin Invest (2011) 0.78
Renin inhibition mitigates anti-angiogenesis in spontaneously hypertensive rats. J Hypertens (2011) 0.78
Novel SCARB2 mutation in action myoclonus-renal failure syndrome and evaluation of SCARB2 mutations in isolated AMRF features. BMC Neurol (2011) 0.78
Effect of experimental hyperglycaemia on renal haemodynamics in prediabetic patients with and without AT1 receptor blockade. Eur J Clin Invest (2010) 0.78
Arterial and retinal vascular changes in hypertensive and prehypertensive adolescents. Am J Hypertens (2013) 0.78
Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis. Liver Transpl (2008) 0.78